2098487-75-1 (PROTAC Sirt2 Degrader-1 | Sirtuin,PROTAC Sirt2 Degrader-1)

Sirt2-PROTAC-1;PROTAC Sirt2 Degrader-1;2098487-75-1;PROTAC-12;Z3847529524;N-[4-[4-[[3-[[2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]-1,3-thiazol-5-yl]methyl]phenoxy]methyl]triazol-1-yl]butyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;DA-66963;HY-103636;G16555;N-[4-(4-{3-[(2-{2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamido}-1,3-thiazol-5-yl)methyl]phenoxymethyl}-1,2,3-triazol-1-yl)butyl]-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxy}acetamide;CHEMBL4225467;GLXC-20368;BDBM50459841;N-{4-[4-({3-[(2-{2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamido}-1,3-thiazol-5-yl)methyl]phenoxy}methyl)-1H-1,2,3-triazol-1-yl]butyl}-2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide;AKOS037653400;EN300-24790949;2-((4,6-Dimethylpyrimidin-2-yl)thio)-N-(5-(3-((1-(4-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butyl)-1H-1,2,3-triazol-4-yl)methoxy)benzyl)thiazol-2-yl)acetamide;CS-0028486;

MFCD31813619

GRYRXFYWVDWPQY-UHFFFAOYSA-N

1S/C40H40N10O8S2/c1-23-15-24(2)44-40(43-23)59-22-34(53)46-39-42-18-28(60-39)17-25-7-5-8-27(16-25)57-20-26-19-49(48-47-26)14-4-3-13-41-33(52)21-58-31-10-6-9-29-35(31)38(56)50(37(29)55)30-11-12-32(51)45-36(30)54/h5-10,15-16,18-19,30H,3-4,11-14,17,20-22H2,1-2H3,(H,41,52)(H,42,46,53)(H,45,51,54)

S1C(NC(CSC2N=C(C)C=C(C)N=2)=O)=NC=C1CC1=CC=CC(=C1)OCC1=CN(CCCCNC(COC2=CC=CC3=C2C(N(C3=O)C2C(NC(CC2)=O)=O)=O)=O)N=N1